US piles on the pressure

Patent law, domestic content rules in solar and ICT policy come under attack

In Court

In Short

Fight over Novartis's patent to intensify

Sri Lanka bans export of high-value medicinal plant

Madras HC dismisses Novartis' petition

Ranbaxy fights Pfizer on generic drugs but wants strong home law on patents

Nagaur breaks free of pharma stranglehold

Rajasthan, Tamil Nadu make quality drugs affordable

No patent linkage

Bayer’s attempt to pre-empt Cipla’s cancer drug fails

Indications of a geographic muddle

Are Geographical Indications safeguarding the interests of growers and artisans?

Black magic

Scientists develop anti-diabetic drug from jamun

Bytes

Andaman and Nicobar: Beyond India's landmass

Excerpts from Troubled Islands! by Pankaj Sekhsaria

Uphill TRIPS

Bid to revive morality, transparency issues in patents regime amid stiff resistance

'Microbes can be patented'

Seeds of discontent?

India's first legislation aimed at protecting farmers' rights raises many apprehensions

Twist in the TRIPS tale

UK panel endorses South's stand on intellectual property rights

Safeguarding ancient wisdom

Traditional Knowledge Digital Library is a useful weapon against wrongful patent

Government's agri-research set-up is undemocratic

India, US tie their first IPR knot

How to save $25 billion and more on drug costs

Patent settlements bring cheaper generics to market early and cut healthcare spending

Spy versus spy and high tech gizmos

From secure manhole covers to Internet tracking systems, NSA has an arsenal of patents

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Best way to check arsenic residues in rice

Biodiversity—India’s other scandal

CAG slams the national biodiversity authority for allowing questionable patents